Dasatinib, a TKI for Bcr-Abl, c-kit, Src family and PDGF receptor signaling, has been used also to treat chronic myelogenous leukemia. This evidence concerns the gene SRC and chronic myelogenous leukemia, BCR-ABL1 positive.